https://www.selleckchem.com/pe....ptide/octreotide-ace
05), alignment (2-3 times less error variance P less then 0.05) and selection of the proper size of the implants (69.23% of correct size femoral implants versus 16.67% using CS P less then 0.0154). Recently, there is mild evidence about benefits in the early rehabilitation and post-operative pain, but in all studies reviewed, there is no advantages of RAS in the long-term functional evaluation. There is no strong literature that supports a longer survival of the prothesis with RAS, being the longest mean follow-up reported